Sponsor Pipeline

FOXG1 Research Foundation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-25 NCT07293546
Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS)		 overall status: Not Yet Recruiting → Enrolling by Invitation
2026-07-25 NCT07293546
Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS)		 date change Primary completion pushed: 2029-03 -> 2029-07
2026-07-25 NCT07293546
Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS)		 date change Completion pushed: 2029-07 -> 2029-12
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07293546 Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS) FOXG1 Syndrome Enrolling by Invitation
Get alerts when FOXG1 Research Foundation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free